Companies
Treatment of leukemia would not be possible without the help of companies developing novel agents.
The ELN Foundation was supported with unrestricted grants by the companies Epicept, Glaxo SmithKline and Pfizer.
Treatment of leukemia would not be possible without the help of companies developing novel agents.
The ELN Foundation was supported with unrestricted grants by the companies Epicept, Glaxo SmithKline and Pfizer.